Emma Walmsley has been GSK CEO since April 2017. She is also a member of the GSK Board. Emma was the CEO of GSK Consumer Healthcare, a Joint Venture between GSK and Novartis, from its creation in March 2015 until her appointment as GSK CEO Designate in September 2016. With a turnover of £6bn in 2015, GSK Consumer Healthcare is one of the world’s largest consumer health companies. Prior to this Emma was President of GlaxoSmithKline Consumer Healthcare and has been a member of GSK’s Corporate Executive Team since 2011. She joined GSK in 2010, with responsibility for Consumer Healthcare, Europe.
Research and development